<DOC>
	<DOC>NCT00442338</DOC>
	<brief_summary>The study estimates the efficacy and safety of MK0476 and aminophylline intravenous administration in adult participants with acute asthma.</brief_summary>
	<brief_title>Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Aminophylline</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Adult participants with acute asthma attacks Participant has any known or suspected, acute or chronic cause for their pulmonary symptoms other than asthma (e.g., COPD, chronic heart failure, etc.). Participant has a smoking habit (15 cigarettes per day) within a month prior to screening period, and/or has a smoking history (20 cigarettes per day) of more than 15 years. Participant has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease.</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>